ClassID:

117246

C12Y305/03006 - CPC Classification

Classification description:

Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amidines (3.5.3) Arginine deiminase (3.5.3.6)

Recent Application in this class:
#1
20260152572
2026-06-04

NOVEL ANTI-PAD2 ANTIBODY

#2
20250215414
2025-07-03

COMBINATION CANCER IMMUNOTHERAPIES WITH ARGININE DEPLETION AGENTS

#3
20250003940
2025-01-02

BIOSENSOR, BIOSENSOR COMPONENTS, AND USE THEREOF

#4
20240293407
2024-09-05

METHODS OF TREATING CANCERS

#5
20240139259
2024-05-02

ENZYME AND PROBIOTICS TAKEN WITH PROTEIN, CREATE A WHOLISTIC SYSTEM THAT PREVENTS THE NEGATIVE EFFECTS OF PROTEIN INDIGESTION ON GUT MICROBIOTA, PROMOTE MICROFLORA BALANCE, AND INCREASE THE BIOAVAILABILITY OF POSTBIOTICS

#6
20240084282
2024-03-14

MODIFIED ARGININE DEIMINASES

#7
20230348884
2023-11-02

Fluorescent Biosensor for Rapid Determination of L-arginine

#8
20230132468
2023-05-04

METHOD FOR PREPARING IMMOBILIZED ARGININE DEIMINASE (ADI) AND PRODUCING [14/15N]-L-CITRULLINE

#9
20220211824
2022-07-07

METHODS FOR TREATING BREAST AND OTHER CANCERS BY TARGETING ARGININOSUCCINATE SYNTHETASE 1-DEFICIENCY

#10
20220105160
2022-04-07

ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT

#11
20210401952
2021-12-30

Method of treating AML subtypes using arginine-depleting agents

#12
20210379167
2021-12-09

Arginine depletion therapy for treatment of GAMT deficiency

#13
20210246225
2021-08-12

NOVEL ANTI-PAD2 ANTIBODY

#14
20210230648
2021-07-29

Arginine supplementation to improve efficiency in gas fermenting acetogens

#15
20200109391
2020-04-09

Arginine deiminase mutant methods of using the same

#16
20190209646
2019-07-11

Bacterial inhibitors

#17
20190136219
2019-05-09

Genetically engineered arginine deiminase modified by site-directed mutagenesis

#18
20180296690
2018-10-18

PROTEIN CONJUGATES

#19
20180296652
2018-10-18

FORMULATIONS OF PEGYLATED ARGININE DEIMINASE

#20
20180251748
2018-09-06

Arginine deiminase mutant and methods of using the same

#21
20180154008
2018-06-07

Methods of treatment with arginine deiminase

#22
20180148749
2018-05-31

Method for producing L-citrulline by using a recombinant strain

#23
20180010114
2018-01-11

Combination cancer immunotherapies with arginine depletion agents

#24
20170240880
2017-08-24

Arginine deiminase gene therapy for disordered proteins

#25
20170159083
2017-06-08

Arginine supplementation to improve efficiency in gas fermenting acetogens

#26
20170000862
2017-01-05

Engineered chimeric pegylated ADI and methods of use

#27
20160206712
2016-07-21

Methods for treating breast and other cancers by targeting argininosuccinate synthetase 1-deficiency

#28
20160115468
2016-04-28

Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein

#29
20160074487
2016-03-17

Arginine deiminase with reduced cross-reactivity toward ADI-PEG 20 antibodies for cancer treatment

#30
20160030532
2016-02-04

Erythrocytes containing arginine deiminase

#31
20160009821
2016-01-14

Antibodies to argininosuccinate synthase and related methods

#32
20150231272
2015-08-20

Methods of treatment with arginine deiminase

#33
20150132278
2015-05-14

Methods of treatment with arginine deiminase

#34
20140348814
2014-11-27

Arginine deiminase with reduced cross-reactivity toward ADI - PEG 20 antibodies for cancer treatment

#35
20130052179
2013-02-28

Arginine deiminase mutant and preparation and application thereof

#36
20100303893
2010-12-02

NOVEL COMPOUND FOR TREATMENT OF TUMOR

#37
20090238813
2009-09-24

Compositions And Methods For Engineered Human Arginine Deiminases

#38
20080274092
2008-11-06

Erythrocytes containing arginine deiminase

#39
20070212311
2007-09-13

Recombinant Alkalinizing Bacteria

#40
20060002915
2006-01-05

Pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis

#41
20050129706
2005-06-16

Method of treatment with modified arginine deiminase